IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — LXRX

Balance Sheet

(in billions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents0.040.040.050.020.060.030.040.100.020.100.030.020.020.060.090.090.10
Short-term Investments0.150.130.070.120.130.220.270.260.200.150.080.120.040.030.030.030.04
Accounts Receivable0.000.010.000.000.050.000.000.000.000.000.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.000.000.000.00--------------
Total Current Assets0.200.190.120.150.250.270.320.360.220.260.110.140.060.090.120.120.15
Property, Plant & Equipment0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Goodwill0.040.040.040.040.040.040.040.040.040.040.040.040.040.040.040.040.04
Total Non-current Assets*0.050.080.080.080.050.050.050.050.050.050.050.050.050.050.050.050.05
Total Assets0.250.270.210.230.300.320.370.420.280.320.160.190.110.140.170.170.19
Accounts Payable0.000.000.000.010.010.010.010.010.010.010.010.010.010.010.010.010.00
Total Current Liabilities0.010.010.020.030.110.040.030.020.030.030.020.020.020.020.030.030.04
Long-term Debt0.050.050.060.060.060.100.100.100.100.100.050.020.020.020.000.000.00
Total Non-current Liabilities*0.060.060.060.060.060.110.110.100.100.100.050.030.020.020.000.000.00
Total Liabilities0.080.070.090.100.170.140.130.130.140.130.070.050.040.040.040.030.04
Retained Earnings(2.05)(2.02)(2.00)(1.99)(1.99)(1.93)(1.87)(1.82)(1.72)(1.67)(1.62)(1.56)(1.54)(1.51)(1.46)(1.44)(1.42)
Total Stockholder Equity0.170.200.120.130.120.180.240.290.140.190.090.140.070.090.140.140.15

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Total Revenue0.6921.105.4914.1828.871.261.551.741.621.090.670.150.29--------0.000.000.00
Cost of Revenue0.040.110.200.010.030.030.350.070.170.030.070.010.01--------0.000.000.00
Gross Profit0.6520.995.2914.1728.831.2326.211.681.481.100.630.160.310.02(0.15)0.07--0.020.230.03
Research & Development17.4412.7611.3118.7615.7515.3026.6925.7817.6414.3714.7617.5614.5412.0310.5613.3614.9315.6810.2612.61
Selling, General & Admin9.759.238.767.609.3511.6132.2639.5939.1932.0632.6132.23----------------
Total Operating Expenses27.1921.9920.0726.3625.1026.9158.9465.3756.8446.43109.7049.7944.55(31.17)(23.13)(24.04)23.4222.9918.1920.87
Operating Income(26.54)(1.00)(14.78)(12.19)3.74(25.68)(32.74)(63.69)(55.35)(45.33)(46.74)(49.63)(44.24)(31.14)(23.09)(24.01)(23.38)(22.96)(17.96)(20.84)
Interest Expense----------------------3.901.961.820.860.700.110.170.170.17
Net Income(31.77)(1.04)(15.53)(12.77)3.25(25.29)(33.77)(64.81)(53.43)(48.40)(49.76)(50.52)(44.90)(31.93)(23.39)(24.59)(23.48)(23.12)(18.07)(20.96)
Basic EPS(0.07)0.00(0.04)(0.04)0.01(0.07)(0.08)(0.18)(0.17)(0.20)(0.20)(0.21)(0.22)(0.17)(0.13)(0.16)(0.16)(0.16)(0.13)(0.15)
Diluted EPS(0.07)0.00(0.04)(0.04)0.01(0.07)(0.08)(0.18)(0.17)(0.20)(0.20)(0.21)----------(0.16)----

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Operating Cash Flow(9.19)(14.73)(17.23)(23.83)16.99(43.78)(21.49)(53.62)(48.54)(55.13)(50.55)(41.62)(38.12)(31.61)(19.44)(24.42)(23.42)(17.15)(21.88)(25.16)
Capital Expenditures----0.000.000.00--0.470.310.250.000.000.080.140.250.000.000.082.18(1.02)0.04
Free Cash Flow*----(17.23)(23.83)16.99--(21.96)(53.93)(48.79)(55.13)(50.55)(41.70)(38.26)(31.86)(19.44)(24.42)(23.50)(19.33)(20.86)(25.20)
Investing Cash Flow(16.46)(70.26)4.8352.1315.4840.5853.7053.47(12.32)(110.22)51.90(39.33)(74.61)12.09(77.20)(13.65)(4.41)(0.40)14.14(17.72)
Financing Cash Flow(0.51)88.76(2.93)0.00(45.00)(0.57)(0.10)(0.92)(0.01)239.38-0.00(0.21)189.00(0.82)94.020.0023.2819.78(0.02)14.27

* Derived from reported values